截圖 iPad iPhone 簡介 This eCOA app is intended for us to collect patient reported data related to the Seqirus V118_24 clincal trial 新內容 2025年2月21日 版本2.11.1 (82) Language Update App 隱私權 開發者「ERT,INC」指出 App 的隱私權實務可能包含下方描述的資料處理。如需更多資訊,請參閱開發...
Seqirus is a biotechnology company involved in vaccine development and production. The company engages in the research, development, and manufacturing of vaccines, particularly for influenza and pandemic preparedness, as well as producing pharmaceuticals such as antivenoms and Q fever vaccine. It is base...
Seqirus V118_2412+ ERT,INC Designed for iPad Free Screenshots iPad iPhone Description This eCOA app is intended for use to collect patient reported data related to the Seqirus V118_24 clinical trial This eCOA app is intended for us to collect patient reported data related to the Seqirus V118...
Visit Our Corporate Siteat seqirus.us Navigate Home flu360 Overview Products Tools & Resources About Help & FAQs Cookie Policy Returns Website Terms of Use Terms and Conditions of Privacy Terms and Conditions of Returnability Terms and Conditions of Use Terms and Conditions of Sale - 2024-2025 ...
爱企查为您提供SEQIRUS2023年企业商标信息查询,包括企业商标注册信息、商标logo,商标类别等企业商标信息查询,让您更轻松的了解SEQIRUS商标信息,查询更多关于SEQIRUS商标信息就到爱企查官网!
Log in to your flu360® account to view your notifications, financial dashboard, and manage your orders today.
Compare Seqirus to Competitors Barinthus Biotherapeutics Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing immunotherapies in the healthcare sector. The company works on guiding T cells to address chronic infectious diseases, autoimmunity, and cancer through its th...
100 years of securing healthy lives CSL Seqirus has a rich heritage in the fight against influenza. As part of CSL, our experience dates back to the deadly 1918 influenza pandemic and we’ve worked with global health partners on the front line of influenza protection ever since. ...
据Fierce Pharma网站6月11日消息,CSL Seqirus公司在美国签约协助禽流感大流行防范工作后,又同意通过一项疫苗供应协议在欧洲开展同样的工作。 欧盟委员会卫生应急准备和反应局(HERA)委托CSL Seqirus为15个欧洲国家提供665000剂禽流感大流行前疫苗。根据为期...
Seqirus, for its part, said the group will utilize artificial intelligence to continually improve flu vaccine R&D. A universal flu shot has been called a "holy grail" in vaccine development, and recent efficacy problems with traditional flu shots have brought new attention to the field. Numerous...